Serotonin Receptor 2C and Insulin Secretion

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Zhang, Qiang ^a   Zhu, Yunxia ^a   Zhou, Wenbo ^a   Gao, Lu ^a   Yuan, Li ^a   Han, Xiao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; INSULIN; PALMITIC ACID; RNA; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; RNA INTERFERENCE; SEROTONIN BLOOD LEVEL;

AMINOPYRIDINES; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; INDOLES; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; PALMITIC ACID; PIPERAZINES; RECEPTOR, SEROTONIN, 5-HT2C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS;

MUS;

EID: 84872586928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054250     Document Type: Article

References (54)

1. Hattersley AT, (2004) Unlocking the secrets of the pancreatic beta cell: man and mouse provide the key. J Clin Invest 114: 314-6.
2. Marchetti P, Lupi R, Boggi U, Filipponi F, Marchetti P, (2010) The beta-cell in human type 2 diabetes. Adv Exp Med Biol 654: 501-14.
3. Holness MJ, Hegazy S, Sugden MC, (2011) Signalling satiety and starvation to β-Cell insulin secretion. Curr Diabetes Rev 7: 336-45.
4. Rodriguez-Diaz R, Abdulreda MH, Formoso AL, Gans I, Ricordi C, et al. (2011) Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab. 14: 45-54.
5. Ahren B, (2000) Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43: 393-410.
6. Kong KC, Tobin AB, (2011) The role of M(3)-muscarinic receptor signaling in insulin secretion. Commun Integr Biol 4: 489-91.
7. Andreazzi AE, Grassiolli S, Mathias PC, Martins AG, de Oliveira JC, et al. (2011) Impaired sympathoadrenal axis function contributes to enhanced insulin secretion in prediabetic obese rats. Exp Diabetes Res 2011: 947917.
8. Harvey JA, Quinn JL, Liu R, Aloyo VJ, Romano AG, (2004) Selective remodelingof rabbit frontal cortex: relationship between 5-HT2A receptor density and associative learning. Psychopharmacology 172: 435-442.
9. Zheng Jiang, Bich-Na Shin, In-Hye Kim, Hyun Joo Lee, Jun-Hwan Yong, et al. (2011) Roles of Non-cholinergic Intrapancreatic Nerves, Serotonergic Nerves, on Pancreatic Exocrine Secretion in the Isolated Perfused Rat Pancreas. Korean J Physiol Pharmacol 15: 307-312.
10. Quickel KE Jr, Feldman JM, Lebovitz HE, (1971) Inhibition of insulin secretion by serotonin and dopamine: species variation. Endocrinology 89: 1295-302.
11. Lechín F, Coll-García E, Van Der Dijs B, Peña F, Bentolila A, et al. (1975) The effect of serotonin (5-HT) on insulin secretion. Acta Physiol Lat Am 25: 339-46.
12. Deeney JT, Bränström R, Corkey BE, Larsson O, Berggren PO, (2007) 3H-serotonin as a marker of oscillatory insulin secretion in clonal beta-cells (INS-1). FEBS Lett 581: 4080-4.
13. Barnes NM, Sharp T, (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083-152.
14. Monti JM, (2011) Serotonin control of sleep-wake behavior. Sleep Medicine Reviews 15: 269-281.
15. Moore MC, Geho WB, Lautz M, Farmer B, Neal DW, et al. (2004) Portal serotonin infusion and glucose disposal in conscious dogs. Diabetes 53: 14-20.
16. Watanabe H, Akasaka D, Ogasawara H, Sato K, Miyake M, et al. (2010) Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover. Endocrinology 151: 4776-4786.
17. Kinoshita M, Ono K, Horie T, Nagao K, Nishi H, et al. (2010) Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol Endocrinol 24: 1978-1987.
18. Nichols DE, Nichols CD, (2008) Serotonin receptors. Chem Rev 108: 1614-41.
19. Vickers SP, Clifton PG, Dourish CT, Tecott LH, (1999) Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology (Berl.) 143: 309-314.
20. Nonogaki K, Strack AM, Dallman MF, Tecott LH, (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat. Med 4: 1152-1156.
21. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, et al. (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374: 542-546.
22. Nonogaki K, Nozue K, Oka Y, (2006) Hyperphagia alters expression of hypothalamic 5-HT2C and 5-HT1B receptor genes and plasma des-acyl ghrelin levels in Ay mice. Endocrinology 147: 5893-900.
23. Hara K, Hirowatari Y, Shimura Y, Takahashi H, (2011) Serotonin levels in platelet-poor plasma and whole blood in people with type 2 diabetes with chronic kidney disease. Diabetes Res Clin Pract 94: 167-71.
24. Lopes de Souza S, Orozco-Solis R, Grit I, Manhães de Castro R, Bolaños-Jiménez F, (2008) Perinatal protein restriction reduces the inhibitory action of serotonin on food intake. Eur J Neurosci 27: 1400-8.
25. Nonogaki K, Nozue K, Oka Y, (2006) Hyperphagia alters expression of hypothalamic 5-HT2C and 5-HT1B receptor genes and plasma des-acyl ghrelin levels in Ay mice. Endocrinology 147: 5893-900.
26. Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, Oksanen LJ, et al. (2007) Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab 6: 398-405.
27. Erdmann J, Pöhnl K, Mayr M, Sypchenko O, Naumann A, et al. (2012) Disturbances of basal and postprandial insulin secretion and clearance in obese patients with type 2 diabetes mellitus. Horm Metab Res 44: 60-9.
28. Iwasawa T, Yasu T, Kubo N, Fujii M, Kuroki M, et al. (2002) Serotonin receptor blockade effective for postprandial vasospastic angina associated with dumping syndrome after esophagectomy: a case report. J Cardiol 40: 19-24.
29. Saini V, (2010) Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes 1: 68-75.
30. Han X, Sun Y, Scott S, Bleich D, (2001) Tissue inhibitor of metal-loproteinase-1 prevents cytokine-mediated dysfunction and cyto-toxicity in pancreatic islets and beta-cells. Diabetes 50: 1047-1055.
31. Zhang HJ, Walseth TF, Robertson RP, (1989) Insulin secretion and cAMP metabolism in HIT cells. Reciprocal and serial passage-dependent relationships. Diabetes 38: 44-48.
32. Zhou YP, Grill VE, (1995) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin 93: 870-876.
33. Du J, Zhang L, Liu S, Wang Z, (2010) Palmitic acid and docosahexaenoic acid opposingly regulate the expression of insulin-degrading enzyme in neurons. Pharmazie 65: 231-2.
34. Hashimoto Y, Naito C, Kume S, Kato H, Watanabe T, et al. (1985) High concentrations of arachidonic acid induce platelet aggregation and serotonin release independent of prostaglandin endoperoxides and thromboxane A2. Biochim Biophys 841: 283-91.
35. Grahame-Smith DG, (1967) The biosynthesis of 5-hydroxytryptamine in brain. Biochem J 105: 351-60.
36. Schraenen A, Lemaire K, de Faudeur G, Hendrickx N, Granvik M, et al. (2010) Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia. 53: 2589-99.
37. Defronzo RA, (2009) Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.
38. Farag YM, Gaballa MR, (2011) Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant 26: 28-35.
39. Roep BO, (2007) Diabetes: missing links. Nature 450: 799-800.
40. Stumvoll M, Goldstein BJ, van Haeften TW, (2008) Type 2 diabetes: pathogenesis and treatment. Lancet 371: 2153-2156.
41. Xu Y, Jones JE, Kohno D, Williams KW, Lee CE, et al. (2008) 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron 60: 582-9.
42. Huang XF, Han M, Storlien LH, (2004) Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity. Brain Res Mol Brain Res 127: 39-47.
43. Di Giovanni G, Di Matteo V, Di Mascio M, Esposito E, (2000) Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35: 53-61.
44. Pozzi L, Acconcia S, Ceglia I, Invernizzi RW, Samanin R, (2002) Stimulation of 5-hydroxytryptamine (5-HT(2C)) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J Neurochem 82: 93-100.
45. Prisco S, Pagannone S, Esposito E, (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J Pharmacol Exp Ther 271: 83-90.
46. Rajan AS, Aguilar-Bryan L, Nelson DA, Yaney GC, Hsu WH, et al. (1990) Ion channels and insulin secretion. Diabetes Care 13: 340-63.
47. Hashimoto Y, Naito C, Kume S, Kato H, Watanabe T, et al. (1985) High concentrations of arachidonic acid induce platelet aggregation and serotonin release independent of prostaglandin endoperoxides and thromboxane A2. Biochim Biophys Acta 841: 283-91.
48. Watanabe RL, Andrade IS, Telles MM, Albuquerque KT, Nascimento CM, et al. (2010) Long-term consumption of fish oil-enriched diet impairs serotonin hypophagia in rats. Cell Mol Neurobiol 30: 1025-33.
49. Baruah MP, Kalra S, (2012) The novel use of GLP-1 analogue and insulin combination in Type 2 Diabetes Mellitus. Recent Pat Endocr Metab Immune Drug Discov 6: 129-35.
50. Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, et al. (2006) Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51: 239-49.
51. Kolar J, Machackova I, (2005) Melatonin in higher plants: occurrence and possible functions. J Pineal Res 39: 333-41.
52. Weiger WA, (1997) Serotonergic modulation of behaviour: a phylogenetic overview. Biol Rev Camb Philos Soc 72: 61-95.
53. Hay-Schmidt A, (2000) The evolution of the serotonergic nervous system. Proc Biol Sci 267: 1071-9.
54. Nekrep N, Wang J, Miyatsuka T, German MS, (2008) Signals from the neural crest regulate beta-cell mass in the pancreas. Development 135: 2151-60.